Abstract
Enzyme-linked immunosorbent assays (ELISAs) can be designed to detect either antigens or antibodies. Nearly all ELISA formats require the separation of reactants from the products of the immunoassay. The product of the assay is an immune complex consisting of target ligand, the analyte, and the reporting probe used to detect the complex that is formed. Because it 1s usually necessary to remove excess analyte as well as excess probe before measurements, several separation steps may be desired, if not required. In the early years, during the evolution of radioimmunoassays (RIAs), it was found that, under certain conditions, antibodies or antigens would bind strongly during brief exposures of solutions to plastic surfaces, such as the inner walls of a tube or a well. The amount of target ligand that would bind proved to be well suited for the competitive assays that were being developed then; the convenience that this phenomen provided has spurred the growth of immunoassay systems for 25 years. Although ELISAs have now generally replaced most RIAs, the principles for coating of the solid phases are similar for both.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barrett J, Dawson G., Gutierrez R, Heller J, Bonewitz D, Webber S, Bairstow C, and Decker R H. (1986) Performance evaluation of the Abbott HTLV-III EIA, a test for anti-HTL V III in donor blood Am J Clin Pathol 86,180ā185
Decker R H. and Dawson G. J. (1989) Recombinant antigens as diagnostic and screening reagents for HIV infections experience with a commercial test, in Genetic Engineering Approaches to AIDS Diagnosis (Luciw P A, Steimer K S, and Overby L R, eds), Dekker, New York, pp 77ā97
Decker R H and Overby L R (1977) Specific problems of radioimmunoassay affecting the quality of performance, in Quality Control in Nuclear Medicine. Mosby, St Louis, MO, pp 427ā436
Hellstrom U. B., Sylvan S P E., Decker R. H, and Sonnerborg A (1993) Immunoglobulin M reactivity towards the unmunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection J Med Virol 39, 325ā332.
Ng V., Chiang C S, DeBouck C., McGrath M., Grove T. H, and Mills J (1989) Reliable confirmation of antibodies to human immnodeficiency virus type 1 (HIV-l) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes J. Clin Microbiol 21,977ā982.
Ng V. L. (1991) Serological diagnosis with recombinant peptides/proteins Clin Chem. 37, 1667,1668.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 1998 Humana Press Inc.
About this protocol
Cite this protocol
Decker, R., Leahy, D. (1998). Immobilization of lmmunoreactants on Solid Phases for ELlSAs. In: Reischl, U. (eds) Molecular Diagnosis of Infectious Diseases. Methods in Molecular Medicineā¢, vol 13. Humana Press, Totowa, NJ. https://doi.org/10.1385/0-89603-485-2:397
Download citation
DOI: https://doi.org/10.1385/0-89603-485-2:397
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-485-3
Online ISBN: 978-1-59259-597-6
eBook Packages: Springer Protocols